BIOMARKERS - An Exclusive Market Insight Report from RI Technologies
RI Technologies' (www.researchimpact.com) report on Biomarkers focuses on the different types of biomarkers and their impact on various disease areas such as oncology, neurology, cardiology and other areas including metabolomic turmoil, arthritis, gynecology, oxidative stress, liver disease, pulmonary disease and aging, etc.
- (1888PressRelease) November 17, 2011 - The study provides global market analysis for biomarkers by the above disease areas and also by prominent biomarker identification technologies including imaging, genomics, proteomics, metabolomics, bioinformatics and other technologies comprising fluorescent indicators, lab-on-chip, nuclear magnetic resonance, mass spectrometry/liquid chromatography and nanobiotechnology. The report offers market values for global geographic regions including United States, Europe, Japan, Asia-Pacific, Canada and Rest of World.
Global Biomarkers market growth would be driven mainly by integration of biomarkers into clinical trials. Biomarkers are expected to increase productivity by identifying potential drug failures in initial stages, leading to savings in time and costs. Biomarkers are becoming an essential part of drug discovery process, bolstering efficiency and accuracy. Biomarkers identification is fast gaining importance, especially in the field of medical research. Latest innovations in the area of transcriptomics, proteomics and metabolomics are driving the trend. Despite Systems Biology providing a better description and understanding of disease pathologies, biomarker identification continues to face challenges. Development of innovative technologies by small and mid-sized companies is prompting major pharma companies to form strategic alliances to identify biomarkers. Current investments in biomarker research and development efforts by pharmaceutical companies would help in discovering a new drug or combinations of biomarker tests. An enormous market opportunity is expected for biomarkers in the near future, as personalized medicine becomes a reality making conventional approaches obsolete.
More information about this report: http://researchimpact.com/Mir003.aspx
RI Technologies offers this report at 20% discount now. For customer support, you may please contact RI Technologies - Email: contactus ( @ ) researchimpact dot com / Phone: +91 9676994272
About RI Technologies
RI Technologies, established in 2006, is a premier source of market research on the Biotechnology & Healthcare sector with exclusive focus on product segments, global and regional market analysis, technology trends, industry outlook, competitor profiles, corporate directory and patents information. The company believes in pure research that will trigger action for immediate customer needs rather than plain reporting of data. The dedicated team works 24/7 to deliver unique reports that are of immense value to investment banks, companies, management consultants, trade associations, corporate executives, business analysts, libraries, universities, and business schools. The company's reports provide strategic information tools to the manufacturers, retailers, distributors, and suppliers that will help them to probe into and support critical business decisions. RI Technologies believes in broadening the value of market research obtained through several dedicated streams of information. The strategic market information tables, graphically represented, will aid companies' research needs and help in forecasting, and gearing up to the future. Emphasis is on factual insights and forecasts with maximum global coverage. The company strives to provide market insight reports that empower customers with enlightening critical business information.
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam